PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2023-10-14

Date Title Company
14-Oct-2023 Avistone Announces Preclinical Results for ANS014004, a Type II c-Met Tyrosine Kinase Inhibitor (TKI) at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics Businesswire
14-Oct-2023 Ankyra Therapeutics Presents Preliminary Phase 1 Canine Clinical Data Evaluating cANK-101 to Treat Advanced Malignant Melanoma in Dogs Businesswire
14-Oct-2023 Verastem Oncology Announces Initial Results of RAMP 203 Trial of Avutometinib and LUMAKRAS™ (sotorasib) in KRAS G12C-Mutant Non-Small Cell Lung Cancer Businesswire
14-Oct-2023 Puma Biotechnology Announces Presentation of Findings from a Phase I/II Study of Alisertib and Pembrolizumab for Rb-Deficient Head and Neck Squamous Cell Carcinomas at the 2023 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Meeting Businesswire
14-Oct-2023 AI-based Clinical Trials Solutions Market Projected to Surge to a US$ 14.2 Billion Valuation by 2032 with a 23.2% CAGR MARKITWIRED
14-Oct-2023 U.S. Food and Drug Administration Approves Opdivo® (nivolumab) as Adjuvant Treatment for Eligible Patients with Completely Resected Stage IIB or Stage IIC Melanoma1 Businesswire
14-Oct-2023 Non-Vascular Stents Market to Reach About US$ 1.9 Billion by 2032, Swayed by Cutting-edge Technology | Future Market Insights,Inc. MARKITWIRED
14-Oct-2023 INFINITY DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Infinity Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm Businesswire